HBK Investments’s Insulet PODD Stock Holding History

HBK Investments’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$2.17M	–	223
2023 Q4	$2.17M	Buy	+10,000	New	+$1.72M	0.01%	156

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBK Investments's PODD Position: Q1 2024 in Review

HBK Investments sold out of Insulet (PODD) in Q1 2024, closing a stake of 67,475 shares — an estimated $14.6M sold.

HBK Investments first reported a position in PODD in Q1 2016 and held it in 9 quarters. The position peaked at $14.6M in Q4 2023. 564 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

HBK Investments reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
HBK Investments sold 67,475 Insulet shares in Q1 2024, an estimated $14.6M.
HBK Investments first reported a position in Insulet in Q1 2016 and held it in 9 quarters.
HBK Investments's Insulet position peaked at $14.6M in Q4 2023.
564 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on HBK Investments's 13F filing for Q1 2024, filed 15 May 2024.